Alex is a 6-year-old boy who was diagnosed with Duchenne muscular dystrophy (DMD) and underwent gene transfer therapy at age 5, and he improved in his ability to both walk and rise from a seated position on the floor. However, he's still fatigued after a long day of activity and has some difficulty with stairs. If you were on the neuromuscular team, what other interventions may be beneficial to optimize his long-term outcome? Listen in as expert panelists discuss this case.
Full Activity on The France Foundation Website:
https://www.francefoundation.com/educ...
This education is designed for healthcare professionals involved in the management of patients with Duchenne Muscular Dystrophy including neurologists and other neuromuscular specialists and is supported by an independent medical educational grant from Sarepta Therapeutics.
The France Foundation
コメント